Rutherford adds biomarker testing to improve the selection of best treatment for cancer patients
A partnership between Rutherford Health plc and OncoDNA, a genomic and theranostic company specialising in precision medicine, will provide Rutherford cancer patients with access to the latest biomarker testing. The partnership will support…
Read more...
Read more...